Legal Opinion

In re Cordarone (amiodarone Hydrochloride) Marketing, Sales Practices & Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided June 2, 2016No. MDL No. 2706PublishedCited by 1 opinion

1Opinion of the Court

ORDER DENYING TRANSFER

Sarah S. Vance, Chair

Before the Panel:* Plaintiff in an action pending in the Northern District of Alabama (Cook) moves under 28 U.S.C. § 1407 to centralize this litigation in the Western District of Texas. The litigation consists of nine actions pending in seven districts, as listed on the attached Schedule A.1

Plaintiffs in three constituent actions and two potential tag-along actions re*1347sponded in support of centralization in the Western District of Texas. Defendant Wyeth Pharmaceuticals Inc. (Wyeth) opposes centralization, as do the self-described “Generic Defendants.”2

2Cases cited3 opinions

  1. In Re Ambulatory Pain-Pumpchondrolysis Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2010
  2. In Re Table Saw Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2009
  3. In re HealthExtras Insurance Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014

3Cited by1 opinion

  1. In re United Collection Bureau, Inc.United States Judicial Panel on Multidistrict Litigation · 2017

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API